Safinamide | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Safinamide
US Patents

Suanfarma, at the Core of a Better Life.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-01-20

Contact Supplier

Safinamide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 12 USDMF, 1 JDMF, 2 EU WC, 3 KDMF, 7 NDC API, 18 Listed Suppliers, $ API Reference Price

25 API Suppliers
12 USDMF
1 JDMF
2 EU WC
3 KDMF
7 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 10 FDA Orange Book, 12 Europe, 4 Australia

26 FDF Dossiers
10 FDA Orange Book
12 Europe
4 Australia

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 1 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem

1 SPI Pharma
3 DKSH
1 Faran Shimi Pharmaceutical
6 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 ACG Worldwide
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
10 Corel Pharma Chem
2 DFE Pharma
6 Gangwal Chemicals
5 Ideal Cures Pvt Ltd
15 Kerry
3 Kima Chemical
6 Lonza Capsugel
8 Microlex e.U
1 Novo Excipients
1 Pharmatrans-Sanaq
1 Pluviaendo
2 Prachin Chemical
1 Qianhao Chemical (Hebei) Co., Ltd
1 Qualicaps
9 Roquette
6 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
2 The Dow Chemical Company
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 23 Fillers, Diluents & Binders, 20 Controlled & Modified Release, 14 Direct Compression, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 8 Film Formers & Plasticizers, 8 Co-Processed Excipients, 7 Granulation, 6 Disintegrants & Superdisintegrants, 5 Empty Capsules, 4 Taste Masking, 4 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Chewable & Orodispersible Aids, 2 Rheology Modifiers, 1 Solubilizers, 1 Topical

43 Coating Systems & Additives
23 Fillers, Diluents & Binders
20 Controlled & Modified Release
14 Direct Compression
12 Thickeners and Stabilizers
12 Lubricants & Glidants
8 Film Formers & Plasticizers
8 Co-Processed Excipients
7 Granulation
6 Disintegrants & Superdisintegrants
5 Empty Capsules
4 Taste Masking
4 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
3 Chewable & Orodispersible Aids
2 Rheology Modifiers
1 Solubilizers
1 Topical

DIGITAL CONTENT

35 NEWS #PharmaBuzz

35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 10 Finished Drug Prices, 1 Annual Reports

1 US Medicaid Prescriptions
10 Finished Drug Prices
1 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

$ API Ref.Price (USD/KG) : 3,170 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6MDD US

filter Patent Number Reset all filters

6 All

01 28076515

02 28278485

03 28283380

filter API Patent Reset all filters

6 All

01 4Y

02 2Blank

filter FDF Patent Reset all filters

6 All

01 2Y

02 4Blank

filter Expiration Date Reset all filters

6 All

01 22027-06-08

02 22028-12-10

03 22031-03-21

Product Main Page

01

MDD US

SAFINAMIDE MESYLATE

PharmaVenue

Not Confirmed

MDD US

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-08

SAFINAMIDE MESYLATE

US Patent Number : 8278485

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

MDD US

SAFINAMIDE MESYLATE

PharmaVenue

Not Confirmed

MDD US

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-21

SAFINAMIDE MESYLATE

US Patent Number : 8283380

Drug Substance Claim :

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-03-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MDD US

SAFINAMIDE MESYLATE

PharmaVenue

Not Confirmed

MDD US

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-12-10

SAFINAMIDE MESYLATE

US Patent Number : 8076515

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-12-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MDD US

SAFINAMIDE MESYLATE

PharmaVenue

Not Confirmed

MDD US

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-12-10

SAFINAMIDE MESYLATE

US Patent Number : 8076515

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-12-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MDD US

SAFINAMIDE MESYLATE

PharmaVenue

Not Confirmed

MDD US

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-08

SAFINAMIDE MESYLATE

US Patent Number : 8278485

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

MDD US

SAFINAMIDE MESYLATE

PharmaVenue

Not Confirmed

MDD US

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-21

SAFINAMIDE MESYLATE

US Patent Number : 8283380

Drug Substance Claim :

Drug Product Claim :

Application Number : 207145

Patent Use Code : U-1993

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-03-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?